DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 123 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,991,662 | +5.0% | 488,318 | +2.1% | 0.08% | +8.3% |
| Q2 2023 | $5,708,586 | -9.5% | 478,106 | +1.3% | 0.07% | -19.1% |
| Q1 2023 | $6,309,089 | -39.4% | 471,884 | -2.4% | 0.09% | -42.6% |
| Q4 2022 | $10,404,576 | +6.0% | 483,484 | -1.3% | 0.16% | +4.0% |
| Q3 2022 | $9,814,000 | +9.3% | 489,972 | -2.3% | 0.15% | +2.8% |
| Q2 2022 | $8,980,000 | +124.4% | 501,689 | +24.3% | 0.14% | +195.9% |
| Q1 2022 | $4,002,000 | -42.2% | 403,458 | -1.9% | 0.05% | -31.0% |
| Q4 2021 | $6,929,000 | -32.3% | 411,207 | -4.7% | 0.07% | -41.3% |
| Q3 2021 | $10,238,000 | +3.5% | 431,446 | -0.7% | 0.12% | -7.6% |
| Q2 2021 | $9,892,000 | – | 434,423 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |